I agree completely, trding. And it’s always bot
Post# of 146082
NP’s insistence on holding on to as much value as possible definitely cuts both ways. I appreciate that tenacity, and it’s that tenacity that has leronlimab where it is. There’s no doubt about that. But it also means that we’ve given up a lot - as a company and as shareholders - to gamble on keeping the whole pot of gold. I was discussing this the other night and summed it up as succinctly as I think possible: I don’t believe that NP prices risk.
Time will give hints as to whether that’s a wise course of action or not, but I think most of us would have preferred a little bit more risk management along the way.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)